UTI vs LOPE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 22, 2026

UTI

47.3
AI Score
VS
UTI Wins

LOPE

45.9
AI Score

Investment Advisor Scores

UTI

47score
Recommendation
HOLD

LOPE

46score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric UTI LOPE Winner
Forward P/E 32.3625 14.3472 LOPE
PEG Ratio 2.16 0.956 LOPE
Revenue Growth 7.2% 6.7% UTI
Earnings Growth -78.9% 18.2% LOPE
Tradestie Score 47.3/100 45.9/100 UTI
Profit Margin 3.9% 19.6% LOPE
Beta 1.00 1.00 Tie
AI Recommendation HOLD BUY LOPE

Relative Price Performance (Last 90 Days)

UTI 1M: -42.2% · 3M: -38.9% LOPE 1M: +5.9% · 3M: -6.0%

Current Technical Phase

UTI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.4%), weak momentum, RSI 26

RSI (14): 25.6 · Price: $22.35

LOPE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 51.2 · Price: $147.46

Fundamentals Snapshot

Metric UTI LOPE
Market Cap
Forward P/E 30.4 13.0
Trailing P/E 39.5 17.7
Revenue (TTM)
Revenue Growth 0.1% 0.1%
Gross Margin 0.6% 0.5%
Operating Margin 0.0% 0.2%
EPS 0.58 8.29
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, UTI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.